Topics

Accent Therapeutics Company Profile

03:55 EST 21st November 2019 | BioPortfolio

Accent Therapeutics is a biopharmaceutical company developing oncology-focused, small molecule therapies in the emerging field of epitranscriptomics. This field of biology encompasses post-transcriptional chemical modifications of RNA that provide cells with a unique mechanism for regulating proteins critical for cellular growth and differentiation. By targeting cancer-linked RNA-modifying proteins (RMPs) with precision therapies, we aim to translate extraordinary science into life-changing therapies for patients. For more information, please visit www.accenttx.com.


News Articles [848 Associated News Articles listed on BioPortfolio]

Accent Therapeutics Taps Tango’s Shakti Narayan for CEO

Shakti Narayan has joined Accent Therapeutics as CEO and member of the company’s board of directors. Narayan comes to Lexington, MA-based Accent from Tango Therapeutics, where he was chief business ...

Accent Therapeutics Appoints Shakti Narayan as Chief Executive Officer

Biopharmaceutical executive strengthens Accent’s leadership team with a strong record of success across the biotechnology and pharmaceutical industries Accent Therapeutics, a biopharmaceutical com...

CRISPR Therapeutics Takes Over Joint Venture Casebia Therapeutics from Bayer

LEVERKUSEN, Germany and ZUG, Switzerland and CAMBRIDGE, Mass., Oct. 21, 2019 /PRNewswire/ — CRISPR Therapeutics and Bayer today announced proposed plans whereby Casebia Therapeutics, a joint ven...

Proteon Therapeutics to merge with ArTara Therapeutics

Proteon Therapeutics, which focuses on kidney and vascular diseases, has signed a definitive agreement to merge with rare and speciality...Read More... The post Proteon Therapeutics to merge with ArTa...

Clover Therapeutics Launches With Eye on Age-Related Ocular Diseases

Clover Therapeutics, which sprung out of Clover Health, is supported by a number of biotech and pharma veterans, including Pfizer veteran Cheng Zhang, who is heading up therapeutics, and Genentech vet...

DGAP-Stimmrechte: Vivoryon Therapeutics AG (deutsch)

Vivoryon Therapeutics AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung DGAP Stimmrechtsmitteilung: Vivoryon Therapeutics AG Vivoryon Therapeutics AG: Veröffen...

iCo Therapeutics Inc. Provides an Update Regarding Oral Amphotericin Study, Marketing and Partnering Activities

Vancouver, British Columbia--(Newsfile Corp. - October 28, 2019) - iCo Therapeutics Inc. (TSXV: ICO) (OTCQB: ICOTF) ("iCo" or "the Company") and its Australian subsidiary, iCo Therapeutics Pty Ltd....

IRW-News: XPhyto Therapeutics Corp.: XPhyto Therapeutics startet Notierung an Frankfurter Börse

IRW-PRESS: XPhyto Therapeutics Corp.: XPhyto Therapeutics startet Notierung an Frankfurter Börse Vancouver (Kanada), 13. August 2019. XPhyto Therapeutics Corp. (CSE: XPHY) (XPhyto oder das Unterne...

PubMed Articles [441 Associated PubMed Articles listed on BioPortfolio]

Effects of Language Background on the Development of Sociolinguistic Awareness: The Perception of Accent Variation in Monolingual and Multilingual 5- to 7-Year-Old Children.

As a result of complex international migration patterns, listeners in large urban centres such as London, UK, likely encounter large amounts of variation in spoken language. However, although dealing ...

Focus Marking and Prosodic Boundary Strength in French.

In French, the size of a focus constituent is not reliably marked through pitch accent assignment as in many stress accent languages. While it has been argued that the distribution of lower-level pros...

Delayed development of phonological constancy in toddlers at family risk for dyslexia.

Phonological constancy refers to infants' ability to disregard variations in the phonetic realisation of speech sounds that do not indicate lexical contrast, e.g., when listening to accented speech. I...

Digital Therapeutics: Emerging New Therapy for Neurologic Deficits after Stroke.

Digital therapeutics is an evidence-based intervention using high-quality software, with the sole purpose of treatment. As many healthcare systems are encountering high demands of quality outcomes, th...

Measurement of mRNA therapeutics: method development and validation challenges.

The progression of chemically modified mRNA therapeutics through development pipelines is accelerating for many disease indications and the need to assess these analytes is becoming more routine for t...

Clinical Trials [207 Associated Clinical Trials listed on BioPortfolio]

Intralesional Steroid Injection Versus Voice Therapy in Management of Vocal Nodules

Vocal nodules represent 16 % of benign vocal fold lesions.They are caused by chronic voice abuse or misuse and often occur in children and adult females. The resultant dysphonia leads to p...

Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular Immunotherapy

The purpose of the study is to assess long-term side effects from subjects who receive a Fate Therapeutics genetically modified NK cell product. Subjects who previously took part in a Fate...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Optimal Sensing in Atrial Tachyarrhythmia's Study

The aim of the study is the comparison of two different leads in their capabilities to detect episodes and duration of paroxysmal atrial fibrillation (AF) and atrial tachyarrhythmia (AT), ...

Companies [1396 Associated Companies listed on BioPortfolio]

Accent Therapeutics

Accent Therapeutics is a biopharmaceutical company developing oncology-focused, small molecule therapies in the emerging field of epitranscriptomics. This field of biology encompa...

Accent on Aesthetics Plastic Surgery Medical Center

As Medical Director of Accent on Aesthetics Plastic Surgery Medical Center, Dr. Howard L. Rosenberg is one of the Bay Area's most sought-after experts on cosmetic enhancement. With over two decades of...

Accent on Integration

Accent on Integration (AOI) enables data sharing by interconnecting healthcare organizations’ disparate technology systems and medical devices using its portfolio of vendor-a...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

More Information about "Accent Therapeutics" on BioPortfolio

We have published hundreds of Accent Therapeutics news stories on BioPortfolio along with dozens of Accent Therapeutics Clinical Trials and PubMed Articles about Accent Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Accent Therapeutics Companies in our database. You can also find out about relevant Accent Therapeutics Drugs and Medications on this site too.

Quick Search

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record